RegWardenFDA facility compliance records
Company

NEUROVISION MEDICAL PRODUCTS, INC.

3 recall(s) on record — most severe on record: Class II.

Recalls by year

FDA actions on record by year2020: 1 recalls; 2024: 1 recalls; 2025: 1 recalls2017201820191202020212022202312024120252026
  • Recalls (3)

Registered facilities (1)

Recalls & enforcement

  • Class IIOngoing2025-05-19
    Product packaging contains the wrong part number and kit contents.
  • Class IIOngoing2024-07-01
    mislabeling; EMG RLN monitoring kit labeling contains the incorrect tube size.
  • Class IITerminated2020-07-21
    The electrode insulating material on the Cobra EMG ET tube used for continuous EMG monitoring may soften over time so that it may be more susceptible to damage by scratching or bending, which could stop or inhibit the EMG signal transmission of the electrodes to the monitor and r…

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. We restate the public record only — measured facts, never risk verdicts.

Cite this record

RegWarden. “NEUROVISION MEDICAL PRODUCTS, INC. — FDA compliance profile.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/company/oo-1930870-neurovision-medical-products-inc/

Not open yet

Alerts for NEUROVISION MEDICAL PRODUCTS, INC.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.